Sanofi Makes Cuts Across the Board

January 2010
Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p9
The article reports on the move of Sanofi Aventis Ltd. to downsize its organization by eliminating at least 750 positions across the board and its oncology business units in the U.S.


Related Articles

  • JEVTANA.  // MPR - Urologists' Edition;Fall2010/Winter2011, Vol. 7 Issue 1, pA4 

    The article offers brief information on Jevtana, an antineoplastic drug from Sanofi Aventis Ltd. which can be used for treatment of hormone-refractory metastatic prostate cancer.

  • ZenithOptimedia on alert as Sanofi-Aventis calls review. Banham, Mark // Campaign;5/21/2010, Issue 20, p8 

    The article reports that Sanofi-Aventis Ltd., pharmaceutical company, reviews its global media planning and buying account and will appoint a single agency to handle its business in Paris, France.

  • Genzyme's Stock Soars on Buyout Speculation.  // Bioworld Week;8/2/2010, Vol. 18 Issue 31, p2 

    The article reports the speculation that the shares of the Genzyme Corporation, the Cambridge, Massachusetts based biotech, which is up to 15.4 percent will be sold to SanofiAventis SA.

  • Sanofi Aventis Strengthens Its Presence in China.  // China Chemical Reporter;8/21/2010, Vol. 21 Issue 16, p21 

    The article reports on the construction of Sanofi Aventis Ltd.'s 410 million-renminbi medicine production factory at Binjian High-Tech Zone in Hangzhou, China on July 20, 2010.

  • SECTION 17: POISONING & DRUG DEPENDENCE.  // Monthly Prescribing Reference;Jul2010, Vol. 26 Issue 7, p274 

    The article offers information on various drugs used in the pharmacologic management of poisoning and drug dependence. It highlights drugs including Digibind from GlaxoSmithKline, Acetadote from Cumberland, and Kayexelate from Sanofi Aventis Ltd. It mentions that Digibind is used for digoxin...

  • Vaccines. Iskowitz, Marc // Medical Marketing & Media;Apr2010, Vol. 45 Issue 4, p52 

    The article presents an analysis on the trends and strategies of pharmaceutical companies to market vaccines in the U.S. It notes top vaccine manufacturers GlaxoSmithKline, Sanofi-Aventis Ltd., and Merck & Co. Inc. have diversified and broad portfolios while Big Pharma has intensified its...

  • Pharmlech blog.  // Pharmaceutical Technology Europe;Sep2010, Vol. 22 Issue 9, p10 

    The article offers world news briefs related to contract services industry including the potential plan of Sanofi Aventis Ltd. to acquire Genzyme, the restriction of the U.S. Food and Drug Administration (FDA) and European authorities on anti-competitive market arrangements and the launch of the...

  • SECTION 1: ALLERGIC DISORDERS.  // Monthly Prescribing Reference;Jul2010, Vol. 26 Issue 7, p1 

    The article presents prescribing notes for several drugs used for treating allergic disorders. It includes Allegra from Sanofi Aventis Ltd., Clarinex from Schering AG, and Singulair from Merck & Co. Inc. Allegra which is classified as antihistamine is indicated for seasonal allergic rhinitis and...

  • SECTION 3: CENTRAL NERVOUS SYSTEM.  // Monthly Prescribing Reference;Jul2010, Vol. 26 Issue 7, p55 

    The article presents prescribing notes for drugs used in the treatment of insomnia. It includes Ambien CR from Sanofi Aventis Ltd., Rozerem from Takeda Pharmaceutical Co. Ltd., and Ativan from Biovail Pharmaceuticals Inc. Rozerem is classified as a melatonin agonist and is contraindicated for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics